The government on Friday said that there is enough stock of hydroxychloroquine in the country and it is taking all steps to ensure that there is not shortage of the drug in the domestic market. India is the biggest manufacturer of the anti - malarial drug that is being touted as "game changer" in teh fight against the Covid-19 pandemic. ( Source Mint )
Meanwhile government has asked the pharma companies to ram up the production of the hydroxychloroquine so that there is no shortage of the drug in the country as well as if demand comes from other countries facing he Coroan Pandemic.
The above news is very much positive for Indian Pharma companies especially IPCA Labs.
Hence one can buy IPCA Labs at CMP of 1,600/- for target of 2300 by December 2020.
Meanwhile government has asked the pharma companies to ram up the production of the hydroxychloroquine so that there is no shortage of the drug in the country as well as if demand comes from other countries facing he Coroan Pandemic.
The above news is very much positive for Indian Pharma companies especially IPCA Labs.
Hence one can buy IPCA Labs at CMP of 1,600/- for target of 2300 by December 2020.
1 comment:
Hey, thanks for the information. your posts are informative and useful.
Sterlite Technologies
Market 2020
Polycab India Ltd
Pioneer Agro Extracts Ltd
Post a Comment